Typical chemical induced disturbances in cardiac function
Effects on heart rate (chronotropic)
Contractility (inotropic)
Conductivity (dromotropic)
Excitability (bathmotropic)
Any xenobiotic that disrupts ion movement or homeostasis may induce a cardiotoxic reaction composed principally of disturbances in heart rhythm
Blood flow through the heart
Blood from superior and inferior vena cava → right atrium → (tricuspid valve) right ventricle → (pulmonary valve) pulmonary artery → lungs → pulmonary veins → left atrium → (mitral valve) left ventricle → (aortic valve) aorta → rest of the body
Cardiac muscle contraction and relaxation
The electrical impulse begins at the SA node (right atrium contracts) → AV node (between atria and ventricles – slows the electrical signal before entering the ventricles) → His-Purkinje network (electrical impulse is sent to the muscular walls of the ventricle – contraction)
Acute cardiac toxic response
Cardiac response to a single exposure to a cardiac toxicant – often manifested as arrhythmia, but myocardial apoptosis and necrosis may also be involved esp if the toxic insult is severe
Chronic cardiac toxic response
Cardiac response to long-term exposure to a cardiac toxicant – often manifested by cardiac hypertrophy and the transition to heart failure
Hypertrophy
Compensatory response of the heart - prolonged HTN, component of cardiac remodeling following IHD, following injury
Heart failure
When the hypertrophic myocardium decompensates resulting to failure – ventricular contractility is reduced
Toxic responses of the heart
Cardiac arrhythmia
Ischemic heart disease
Cardiomyopathies
Apoptosis and oncosis
Mitochondrial injury
Cardiac arrhythmia
Interference with ion homeostasis
Xenobiotics that can induce cardiac arrhythmia
5-Fluorouracil
Cyclophosphamide
Halogenated hydrocarbons
Interferon – γ
Ketones
TCAs
Toluene
Inhibition of Na+-K+ ATPase
Increases Na+ and subsequently Ca++ resulting to positive inotropy
Xenobiotics that inhibit Na+-K+ ATPase
Cardiac glycosides (digoxin)
Na+ channel blockade
Reduced cardiac excitability
Xenobiotics that block Na+ channels
Amphotericin B
Class I antiarrhythmics
Cocaine
Local anesthetics
SSRIs
K+ channel blockade
Increases AP duration and refractoriness
Xenobiotics that block K+ channels
Antihistamines
Cisapride
Class III antiarrhythmics
Fluoroquinolones
Macrolides
Ca++ channel blockade
Produces negative inotropy
Xenobiotics that block Ca++ channels
Aminoglycosides, Tetracycline, Chloramphenicol, Amphotericin B
Class IV antiarrhythmics
Phenothiazine antipsychotics (chlorpromazine…)
SSRIs
Sarcolemmal injury, sarcoplasmic reticulum dysfunction, and Ca++ overload
Alterations of cardiac calcium homeostasis by toxicants may disturb the regulation of cellular function
Xenobiotics that cause sarcolemmal injury, sarcoplasmic reticulum dysfunction, and Ca++ overload
Altered cardiac contractility and coronary blood flow. Xenobiotics that alter cardiac contractility and disturb myocardial perfusion may result to ischemia. Prolonged ischemia may lead to MI
Oxidative stress – ROS are generated during myocardial ischemia and at the time of reperfusion. Toxicants may induce cardiotoxicity through the generation of ROS
Atherosclerosis – buildup of fat and cholesterol plaques in and on the walls of blood vessels – block blood flow, and may form dangerous clots
Cardiomyopathies
General term for diseases of the heart muscle, where the walls of the heart chambers have become stretched, thickened, or stiff. Causes: IHD, hypertrophy, infectious diseases, drug or chemical-induced, idiopathic
Dilated cardiomyopathy
Produced by progressive cardiac hypertrophy, decompensation, ventricular dilation, leading to systolic dysfunction, or impaired contractility
Hypertrophic cardiomyopathy
Produced by progressive cardiac hypertrophy, with impaired compliance of the ventricular walls and reduced diastolic ventricular filling
Xenobiotics that can cause cardiomyopathies
Ethanol (chronic, for acute – reduced conductivity)
Mineralocorticoids
Natural and synthetic androgens
Natural and synthetic glucocorticoids
Nucleoside analog reverse transcriptase inhibitors (zidovudine…)
Apoptosis and oncosis
Myocyte death – peptides and cytokines directly activate apoptotic signaling pathways. Xenobiotics may induce cardiac myocyte apoptosis